Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3218399
Max Phase: Preclinical
Molecular Formula: C35H55N13O16
Molecular Weight: 913.90
Molecule Type: Small molecule
Associated Items:
ID: ALA3218399
Max Phase: Preclinical
Molecular Formula: C35H55N13O16
Molecular Weight: 913.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](OC(=O)NCCCCc2cn(CCCNC(=O)O[C@@H]([C@@H]3OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]3NC(C)=O)[C@H](O)CO)nn2)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N
Standard InChI: InChI=1S/C35H55N13O16/c1-15(51)42-24-18(44-32(36)37)10-22(30(55)56)61-28(24)26(20(53)13-49)63-34(59)40-7-4-3-6-17-12-48(47-46-17)9-5-8-41-35(60)64-27(21(54)14-50)29-25(43-16(2)52)19(45-33(38)39)11-23(62-29)31(57)58/h10-12,18-21,24-29,49-50,53-54H,3-9,13-14H2,1-2H3,(H,40,59)(H,41,60)(H,42,51)(H,43,52)(H,55,56)(H,57,58)(H4,36,37,44)(H4,38,39,45)/t18-,19-,20+,21+,24+,25+,26+,27+,28+,29+/m0/s1
Standard InChI Key: BUZVBQWEPJJXRM-XUGABSMISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 913.90 | Molecular Weight (Monoisotopic): 913.3890 | AlogP: -5.67 | #Rotatable Bonds: 23 |
Polar Surface Area: 463.35 | Molecular Species: ZWITTERION | HBA: 19 | HBD: 16 |
#RO5 Violations: 3 | HBA (Lipinski): 29 | HBD (Lipinski): 18 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.08 | CX Basic pKa: 11.82 | CX LogP: -10.17 | CX LogD: -10.17 |
Aromatic Rings: 1 | Heavy Atoms: 64 | QED Weighted: 0.03 | Np Likeness Score: -0.01 |
1. Fraser BH, Hamilton S, Krause-Heuer AM, Wright PJ, Greguric I, Tucker SP, Draffan AG, Fokin VV, Sharpless KB. (2013) Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza A and B, 4 (2): [10.1039/C2MD20300F] |
Source(1):